[P3] A

[P3-013-A] A new PCV2 and Mycoplasma hyopneumoniae vaccine administered with needle-syringe or needle-free device demonstrates uncompromised efficacy against PCV2-d challenge

Roman KREJCI Krejci¹, *Philippe Mazerolles¹, István Kiss², Nimród Pálmai ², Tamas Révész³, Han Smits², Gwenaelle Dauphin² (1. Ceva (France), 2. Scientific Support and Investigation Unit, Ceva-Phylaxia (Hungary), 3. Ceva Phylaxia (Hungary))

Keywords:

Mycoplasma hyopneumoniae,PCV-2d,Vaccine